Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

REWIND Investigators

Research output: Contribution to journal › Article › peer-review

1808 Scopus citations

Fingerprint

Dive into the research topics of 'Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial'. Together they form a unique fingerprint.

Medicine and Dentistry